PANCREATIC CARCINOMA

This study is testing how well and how safely the diabetes drug glipizide works to lower high blood sugar in people with pancreatic cancer. It involves 29 participants who have active pancreatic cancer and high blood sugar levels. Researchers are comparing blood sugar levels befo…

This study aims to find the best way to monitor pancreatic cysts, which can sometimes develop into cancer. It compares two different schedules of scans and tests: one with more frequent monitoring and one with less. The goal is to see which approach leads to better health outcome…

This early-stage study is testing the safety of combining a new cancer vaccine with an existing immunotherapy drug (pembrolizumab) for patients with advanced solid tumors that have spread and stopped responding to standard treatments. The vaccine is designed to train the immune s…

This trial is for people whose advanced pancreatic cancer has spread and has a specific genetic change (BRCA1, BRCA2, or PALB2 mutation), and whose first treatment stopped working. It compares a standard two-drug chemotherapy to a new three-drug combination, to see if adding a th…

This early-phase study is testing a new radioactive tracer called 18F-αvβ6-BP to see if it can help doctors better locate cancer in the body. The tracer is given by IV, and then patients undergo several PET scans to see where it collects. The main goals are to check the safety of…

This study is testing whether pancreatic enzyme replacement therapy (PERT) can help people with advanced pancreatic cancer maintain their body weight while on chemotherapy. Researchers are comparing two different dosing schedules of the enzyme supplement pancrelipase. The main go…

This study is testing whether personalized education and genetic counseling can encourage more people with a family history of pancreatic cancer to get genetic testing. Researchers are working with 40 patients at Mayo Clinic Florida who have a close relative with pancreatic cance…

This study is testing a web-based education tool called HOPE-Genomics to see if it helps cancer patients better understand their personal genetic test results and general cancer genomics. Researchers are comparing the tool's effectiveness against standard education methods in abo…